{"slideshow_credits": null, "snippet": "Merck is paying only about 4.3 times Cubist\u2019s estimated revenue for next year \u2014 about the same multiple investors give Merck itself, making the acquisition look like a relative bargain, writes Robert Cyran of Reuters Breakingviews.", "abstract": "Merck is paying only about 4.3 times Cubist\u2019s estimated revenue for next year \u2014 about the same multiple investors give Merck itself, making the acquisition look like a relative bargain, writes Robert Cyran of Reuters Breakingviews.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://dealbook.nytimes.com/2014/12/08/revival-for-antibiotics-could-spur-deals/", "lead_paragraph": null, "headline": {"main": "Revival for Antibiotics Could Spur Deals", "kicker": "DealBook"}, "_id": "5485ff1a38f0d8164e21dad8", "word_count": "388", "multimedia": [{"height": 126, "url": "images/2014/12/09/business/dbpix-merck/dbpix-merck-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/12/09/business/dbpix-merck/dbpix-merck-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/12/09/business/dbpix-merck/dbpix-merck-articleLarge.jpg", "legacy": {"xlarge": "images/2014/12/09/business/dbpix-merck/dbpix-merck-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/12/09/business/dbpix-merck/dbpix-merck-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/12/09/business/dbpix-merck/dbpix-merck-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-12-08T14:39:29Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Cubist Pharmaceuticals Inc", "name": "organizations", "rank": "1"}, {"value": "Merck & Company Inc", "name": "organizations", "rank": "2"}, {"value": "Antibiotics", "name": "subject", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}